Your browser doesn't support javascript.
loading
What are the competency requirements for clinical pharmacist verification of systemic anti-cancer therapy (SACT) prescribed within a clinical trial? A consensus study.
Gilluley, Nikki; Bennie, Marion; Elliott, Ben.
Affiliation
  • Gilluley N; Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, UK.
  • Bennie M; NHS Lothian Pharmacy Service, Edinburgh, UK.
  • Elliott B; Strathclyde Institute of Pharmacy & Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow, UK.
J Oncol Pharm Pract ; 28(7): 1524-1533, 2022 Oct.
Article in En | MEDLINE | ID: mdl-34250848
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacists / Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pharmacists / Neoplasms Type of study: Guideline Limits: Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom